← All Conditions

A Scan or Blood Test Has Flagged Something in Your Chest
What Happens Next

Whole-body MRI, full-body CT and multi-cancer blood tests are designed to check the whole body. They often report a finding in the chest without identifying what it is. The test that identifies it depends on where in the chest it lies, and choosing the wrong test has led to unnecessary operations. Dr Lawrence Okiror, Consultant Thoracic and Robotic Surgeon (GMC 6150382), reviews the report and the images, explains what the finding is likely to be, and advises whether anything further is needed. Appointments at London Bridge Hospital and The Lister Hospital Chelsea within 2–3 days, including video consultations. Self-referrals welcome.

Last reviewed: October 2026 · Dr Lawrence Okiror FRCS(CTh) FRCSEd(CTh) · GMC 6150382

A Second Test Is Usually Needed

These scans cover the whole body at a general level of detail. They are good at detecting an abnormality and less good at identifying it. A second, targeted test is usually needed, and the right one depends on where in the chest the finding lies.

Each Scan Has Known Weaknesses

CT can make a harmless cyst at the front of the chest look solid. MRI can make a harmless rib lesion look aggressive, and it misses small lung nodules. Knowing these weaknesses is a large part of interpreting the report.

Most Need No Operation

For most people who send me one of these reports, the outcome is reassurance with a set follow-up date, or a single targeted scan. Surgery is arranged only for the few who need it.

Why does the same finding mean something different on a health-check scan?

When a scan is arranged for a symptom, a risk factor or an abnormal result, the doctor already has a reason to suspect something, and the images are read with that in mind. A scan bought as a health check has no such starting point. You were well and nothing prompted the scan, so the likelihood of serious disease was low beforehand and is usually still low afterwards.

The finding still needs to be assessed properly. It should be interpreted with that low starting likelihood in mind. A report written without this context can sound more definite than the evidence supports, and phrases such as likely represents and cannot be excluded often describe a small possibility.

The sections below set out what these scans and tests do well, where they are weaker, and the sensible next step for each part of the chest. The chest imaging page explains what CT, MRI and PET each contribute and what common phrases in a radiology report mean.

Which scan identifies
what a chest finding is?

The chest has five main areas. In each one, a different scan is best at identifying a finding, and each scan has its own typical errors.

The front of the chest: the thymus and the area in front of the heart

Which scan detects it
CT detects lesions in the front of the chest. It is the standard scan for measuring them and for following them over time.
Which scan identifies it
A targeted chest MRI answers two questions that CT cannot: whether the lesion contains fluid or is solid, and whether an enlarged thymus is normal tissue or a tumour. Both need short additional MRI sequences that are not part of a screening scan.
Typical error
On CT, a benign thymic cyst can look solid, because a cyst containing protein has a similar density to a tumour. One specialist centre reported that around 44 per cent of its thymus operations had been unnecessary, largely for this reason.
Next step
If a report raises the possibility of a thymoma, the usual next step is a targeted MRI before any discussion of surgery. The thymoma page and the mediastinal surgery page explain these findings and when they need removing.

The middle and back of the mediastinum, where cysts are common

Which scan detects it
CT detects these reliably. They are usually reported as a smooth, rounded mass near the windpipe or just below where it divides.
Which scan identifies it
MRI, and one sequence is often enough. A bronchogenic or foregut cyst appears bright on one type of MRI image and does not take up contrast in the way a solid tumour does.
Typical error
As at the front of the chest, CT can make a cyst look solid. Only about half of these cysts contain clear fluid. The rest contain protein or old blood, which gives them the density of solid tissue on CT. In one published series of 68 cysts, 14 looked solid on CT, and MRI showed that nine of these contained fluid.
Next step
A mass reported here is not necessarily a tumour, and an MRI before any surgical discussion is reasonable. The mediastinal surgery page lists the other possible causes.

The ribs, breastbone and spine

Which scan detects it
CT. In bone, the same scan both detects and identifies the lesion, because CT shows the internal structure of bone more clearly than any other test.
Which scan identifies it
CT. MRI is used alongside it to show whether the bone marrow is involved and whether anything extends into the surrounding soft tissue.
Typical error
MRI shows swelling in the marrow and soft tissue around a bone lesion, and this can make a benign lesion look aggressive. For one common benign bone tumour, CT identified the lesion more accurately than MRI in around two-thirds of cases.
Next step
A rib or breastbone finding that looks worrying on MRI should have a CT before any conclusion is drawn. See the chest wall lump page and the rib page.

The lungs

Which scan detects it
CT. In the lungs, the choice of scan determines whether a small finding is seen at all.
Which scan identifies it
CT, followed if needed by a repeat CT after an interval to check for change. Size, outline, density and growth over time distinguish a harmless nodule from one that needs treatment.
Typical error
MRI can give false reassurance. It matches CT for lung nodules larger than about eight millimetres. Below that size it becomes less reliable, and at four millimetres or smaller it misses more nodules than it detects. These figures come from scanners running dedicated lung sequences, which a whole-body protocol does not include.
Next step
A whole-body MRI reported as clear in the chest has not examined the lungs to the standard of a CT. If lung cancer is the concern, because of smoking history, family history or occupational exposure, a CT is needed. See what a lung nodule is and the shadow on a scan page. A nodule reported on a calcium score or CT coronary angiogram is covered on the nodule found on a heart scan page.

The chest wall and the lining of the lung

Which scan detects it
CT, which shows both the soft tissue and the bone.
Which scan identifies it
MRI for soft-tissue lesions. Ultrasound for lesions close to the skin, with the advantage that a needle sample can be taken at the same appointment if needed.
Typical error
Here the more common problem is under-reporting. Thickening of the lining of the lung is the usual example, and it needs to be read alongside the person's history.
Next step
Pleural thickening on a screening scan should prompt a question about past asbestos exposure. This is covered on the asbestos-related pleural disease page. For a lump you can feel, see the chest wall lump page.
Which scan answers which chest question
Where in the chestWhich scan identifies it
Front of the chest and thymusCT detects it; targeted MRI shows whether it contains fluid or is solid
Middle and back of the mediastinumCT detects it; MRI shows whether it is a benign cyst
Ribs, breastbone and spineCT detects and identifies it; MRI can make it look more serious than it is
LungsCT detects and identifies it; MRI misses small nodules
Chest wall and lining of the lungCT detects it; MRI or ultrasound identifies it

My report mentions a possible thymoma.
How worried should I be?

Usually less than the word suggests. The thymus lies directly behind the breastbone. It is a normal organ, often still visible in younger adults, and it can enlarge again after illness, physical stress, steroid treatment or chemotherapy. It is therefore seen often on chest imaging, and a scan looking for cancer will often mention it in the report.

How the shape helps

Normal thymus is triangular or arrowhead-shaped, with a smooth outline, two symmetrical lobes and no separate lump within it. A thymoma is a distinct rounded or lobulated mass, separate from the surrounding tissue. Age is also relevant: a normal or enlarged thymus is common in younger adults and becomes less common with age.

Shape does not always settle the question, and this is why additional MRI sequences are used. In one published case, a thymoma looked smooth and symmetrical on CT and was reported as an enlarged normal thymus. It was correctly identified only when the additional MRI sequences were performed.

The MRI sequence that answers the question adds a few minutes to the scan. It detects microscopic fat within the tissue. Normal and enlarged thymus contains this fat and a thymoma does not, so the signal drops in normal tissue and stays the same in a thymoma. In published series this separates the two almost completely. The sequence is not part of a whole-body screening protocol, so if your scan has raised the question, the test that answers it has usually not yet been done.

Thymic cysts cause a separate problem. A thymic cyst is a benign fluid-filled sac that needs no treatment. If it contains protein, it can have the same density on CT as a solid tumour, and a small cyst next to the aorta can appear to take up contrast when it has not. This is how unnecessary thymus operations come about, and one targeted MRI usually prevents it.

What happens if a cancer blood test is positive
but the scans are clear?

This is the situation people find hardest. A blood test has reported a cancer signal, a scan has been arranged, and it has found nothing, or found something unrelated. At present there is no agreed answer in medicine on what should happen next.

Two facts help. First, in people without symptoms, a positive result on these tests is more often a false alarm than a true one. This is because serious disease is uncommon in a well population. Even a very accurate test produces more false positives than true positives when it is used in people who are unlikely to be ill.

Second, resolving a result takes months

In the largest published study of a multi-cancer blood test used in this way, resolving a positive result took around two months when a cancer was eventually found, and around five months when no cancer was found. A quarter of people waited eight months or longer. A later and larger study reported shorter times, but false alarms still took longest to resolve.

Published work in this field states that it is not known how closely people should be followed when the first round of tests is negative or inconclusive. A fixed surveillance protocol offered with confidence goes beyond the current evidence.

My role is to deal with the chest. I review the images themselves, decide whether anything in the chest needs further investigation, and give you a set follow-up interval with a clear end point. If nothing in the chest needs further action, I will tell you so.

The test most people have heard of may not be the one they have had. Galleri is the most widely reported multi-cancer blood test and was the subject of a large NHS trial that reported in 2026. For several years it was available in the UK only within that trial. It carries a UKCA mark, and during 2026 it began to be offered privately by a small number of UK providers. It is not available on the NHS. UK clinics also sell several other tests, and a positive result means different things for each. Please bring the actual report rather than the name of the test.

What happens when you
send me the report?

Most people who send me one of these reports do not need an operation. The usual outcome is an explanation, reassurance with a set follow-up date, or one targeted scan. I say this at the start because a surgeon's page can easily be read as a recommendation for surgery.

At the consultation I review the images themselves, not only the report. Reports are written cautiously and often sound less certain than the images are. Going through the images with you and explaining what they show is usually the most useful part of the appointment, and most people have not yet had this done.

If further imaging is needed, it is a single scan aimed at the specific question. If you live at a distance, it can usually be arranged locally and reviewed at a follow-up appointment. Only the few who need an operation come to London, to London Bridge Hospital or The Lister Hospital Chelsea. When surgery is needed, it is usually within a week of completing investigations.

Findings outside the chest

These scans often report findings outside the chest, in the liver, kidneys, adrenal glands, prostate, spine or brain. These are outside my specialty and I do not manage them. I will tell you which of them appear to need a specialist opinion and which are common and harmless.

I also do not comment on whether you should have had the test. Most people choose these tests after careful reading, and my role begins once the result exists.

Appointments at London Bridge Hospital and The Lister Hospital Chelsea are usually available within 2–3 days, including video consultations, and patients are seen from across the UK and abroad. Where a case is uncertain, it is discussed at the chest multidisciplinary team meeting before any decision about surgery. If you have already received an opinion you are unsure about, you can ask for a second opinion.

Clinics and radiologists who reported the finding and wish to refer the patient directly can use the referral route for imaging and screening clinics, which sets out what to send and what is returned.

Where do the figures
on this page come from?

The figures above are given in plain terms. The underlying data and references are listed below.

  • Unnecessary thymus surgery. A non-therapeutic thymectomy rate of approximately 44% has been reported from a quaternary referral centre, attributed to misinterpretation of chest CT and concern for thymoma. Ackman JB et al; discussed in the BTOG Thymic Malignancies Special Interest Group diagnostic algorithm, Clinical Radiology, 2024.
  • Thymic cysts on CT. A thymic cyst is typically round or oval with a smooth contour, homogeneous fluid attenuation below 20 HU and thin or imperceptible walls, but may exceed 20 HU because of high protein content, and small cysts adjacent to the aorta may show pseudo-enhancement. BTOG Thymic Malignancies SIG, Clinical Radiology, 2024.
  • Separating thymic hyperplasia from thymoma. Dual-echo chemical-shift MRI distinguished hyperplastic thymus from anterior mediastinal tumours with 100% sensitivity and 100% specificity at a signal intensity index cut-off of 8.92%, and 100% sensitivity with 96.7% specificity at a chemical-shift ratio cut-off of 0.849 (n=92). Priola AM et al, Radiology 2015;274:238–249 (PMID 25105246). Mean chemical-shift ratio 0.614 ± 0.130 in hyperplasia versus 1.026 ± 0.039 in tumours: Inaoka T et al, Radiology 2007. Chemical-shift ratio values overlap in early adulthood, and the proposed signal intensity index cut-off has been the subject of published debate.
  • Mediastinal cysts appearing solid. Approximately half of bronchogenic cysts show water attenuation and half soft-tissue attenuation because of protein, haemorrhage or calcium oxalate content. In a series of 68 cysts, 25 of 62 imaged by CT showed soft-tissue attenuation; 14 appeared solid on morphology and attenuation, and MRI in nine of these showed marked T2 hyperintensity. McAdams HP et al, Radiology 2000;217:441–446 (PMID 11058643).
  • Bone lesions. CT was more accurate than MRI in detecting the osteoid osteoma nidus in 63% of cases, while MRI was better at showing intramedullary and soft-tissue change in all cases, which may produce a misleadingly aggressive appearance. Assoun J et al, Radiology 1994;191:217–223 (PMID 8134575). CT is described as the main diagnostic imaging test for chest wall lesions in AJR, 2011.
  • MRI and lung nodules. Pooled per-lesion sensitivity of MRI for nodules ≥4 mm was 87.7% (95% CI 81.1–92.2), rising to 98.5% for nodules 8–10 mm and falling to 80.5% below 8 mm (systematic review, CRD42023437509, Radiology: Cardiothoracic Imaging 2024). In a direct comparison of 113 nodules, MRI sensitivity was 57.1% at ≤4 mm, 75% at 4–6 mm, 87.5% at 6–8 mm and 100% above 8 mm: Cieszanowski A et al, PLOS One 2016;11:e0156272. A meta-analysis found CT statistically superior to MRI on sensitivity, specificity and AUC, concluding MRI cannot replace CT for pulmonary nodules. These figures derive from dedicated lung MRI protocols, which whole-body screening protocols do not use.
  • Time to resolve a positive blood test. In the PATHFINDER study, median time to diagnostic resolution was 79 days overall: 57 days in true positives and 162 days in false positives (IQR 44–248). Schrag D et al, The Lancet 2023. In the larger PATHFINDER 2 cohort (35,878 participants, presented at ASCO 2026), median diagnostic resolution was 48 days, cancer signal origin accuracy 91.3%, and 0.6% of participants underwent an invasive procedure, of which 90.5% were non-surgical.
  • Uncertainty about follow-up. Published analysis of cancer signal origin prediction and diagnostic resolution in PATHFINDER states that participants with risk factors and negative or equivocal initial evaluation remain at risk of subsequent cancer diagnosis, and that it is uncertain how closely such individuals should be followed. Cancer Prevention Research 2025;18(8):475.
  • The NHS-Galleri trial. Reported at ASCO in May 2026, the trial did not meet its primary endpoint of reducing the combined number of cancers diagnosed at stage III or IV. It reduced stage IV diagnoses, increased overall detection when added to standard screening, raised stage I–II diagnoses, and reduced diagnoses made through emergency presentation. Longer follow-up is awaited.
  • Availability of Galleri in the UK. The Galleri test carries a UKCA mark. Until 2026 it was available in the UK only within the NHS-Galleri trial; private provision began during 2026 through a small number of UK clinical providers and private GP clinics. It remains unavailable on the NHS, and the NHS-Galleri trial website continues to state that the test cannot be bought in the UK, reflecting the position before commercial launch.
  • Screening guidance. The UK National Screening Committee does not recommend whole-body screening in healthy adults. ESMO recommends low-dose CT screening for lung cancer through established programmes in current or former smokers aged 55–74 with a defined smoking history (Zer A et al, Annals of Oncology 2025;36:1245–1262). No guideline body recommends whole-body imaging or a blood test for lung cancer detection.

Questions About
Chest Findings on Private Scans and Blood Tests

Questions people ask after a whole-body scan, a full-body CT or a cancer blood test has reported something in the chest.

Book a Consultation →

Or call Jo Mitchelson:
020 7952 2882

A whole-body scan has found something in my chest. What should I do first?
Have the finding properly identified before arranging any further scans. Almost all of these findings turn out to be benign. The useful next step is one targeted test aimed at the specific question your scan has raised, rather than another whole-body scan. Which test depends on where in the chest the finding lies: the front of the chest, the lungs, the ribs and breastbone, the lining of the lung or the chest wall. Bring the images as well as the report, because the images often show more than the report describes.
Why does it matter that the scan was a health check rather than done for symptoms?
Because it changes what the same appearance is likely to mean. When a scan is arranged for a symptom, a risk factor or an abnormal test, there is already a reason to suspect something, and the finding is read with that in mind. A health-check scan has no such reason behind it. The person is well, and the likelihood of serious disease is low before the scan. The finding still needs proper assessment, but it should be interpreted with that low starting likelihood in mind.
Which is better for the chest, whole-body MRI or full-body CT?
Neither is better overall. Each is better in different parts of the chest, and each has typical errors. CT is more reliable for the lungs, ribs and breastbone. MRI is better at showing whether a lesion at the front of the chest contains fluid or is solid. In the mediastinum, CT can make benign cysts look solid. In bone, MRI can make a harmless lesion look aggressive. In the lungs, MRI misses small nodules that CT would detect. The right scan is the one that answers the specific question your finding has raised.
My report mentions a possible thymoma. How worried should I be?
Usually less than the word suggests. The thymus lies at the front of the chest, is often still visible in younger adults, and can enlarge again after illness, stress or chemotherapy. Normal thymus is triangular or arrowhead-shaped, with a smooth outline and no separate lump within it. A thymic cyst, which is benign and fluid-filled, can have the same density on CT as a solid tumour, and this has led to unnecessary thymus operations. A short additional MRI sequence detects microscopic fat in normal and enlarged thymus, which a thymoma does not contain. In published series it separates the two almost completely. It adds a few minutes to the scan and is not part of a screening protocol.
My scan was clear in the chest. Does that rule out lung cancer?
Not if the scan was a whole-body MRI. MRI performs almost as well as CT for lung nodules larger than about eight millimetres. Below that size it becomes less reliable, and at four millimetres or smaller it misses more nodules than it detects. These figures come from scanners using dedicated lung sequences, which whole-body screening protocols do not include, so performance in practice is lower. A chest reported as clear on whole-body MRI has not had its lungs examined to the standard of a CT. This is a limitation of the technique, and it is rarely explained when the scan is sold.
I have had a positive cancer blood test but my scans are clear. What now?
There is no agreed answer to this situation at present. In the largest published study of this type of test, resolving a positive result took around two months when cancer was eventually found and around five months when it was not. A quarter of people waited eight months or more. Published work states that it is not known how closely people should be followed when the first round of tests is negative or inconclusive. I can take responsibility for the chest: review the imaging, decide whether anything in the chest needs further investigation, and give you a set follow-up interval with a clear end point.
Is the Galleri test available in the UK?
Availability has changed recently, so you may find conflicting information. For several years Galleri was available in the UK only within the NHS-Galleri trial. The trial reported its main results in 2026. It did not meet its primary endpoint, but it reduced the number of cancers found at the most advanced stage and increased the number found early. The test carries a UKCA mark, and during 2026 it began to be offered privately in the UK by a small number of clinical providers and private GP clinics. It is not available on the NHS. The trial website still states that the test cannot be bought in the UK, which reflects the position before the private launch. UK clinics also sell other cancer blood tests, and a positive result means different things for each, so please bring the actual report.
Will you just tell me the scan was a waste of money?
No. Most people choose these tests after careful reading, and a lecture afterwards would not help. These tests do detect real abnormalities. They are less good at identifying them, and that is where problems arise: unnecessary operations, long periods of uncertainty, and false reassurance about the lungs. My role is to interpret the chest findings. Whether you should have had the test is not part of the consultation.
Do I have to come to London to be seen?
Not necessarily. Appointments are available at London Bridge Hospital and The Lister Hospital Chelsea within 2–3 days, with outpatient clinics at Canary Wharf and the City of London, and video consultations where travel is difficult. Reviewing a report and images works well by video, and patients are seen from across the UK and abroad. If further imaging is needed, it can usually be arranged closer to home and reviewed at a follow-up appointment. Only the few who need an operation come to London for it.
My scan also found things outside the chest. Can you deal with those?
No. These scans often report findings in the liver, kidneys, adrenal glands, prostate, spine and brain, and these are outside my specialty. I will deal with the chest, and I will tell you which of the other findings appear to need a specialist opinion and which are common and harmless.
Will my insurance cover this?
Usually the consultation is covered and the original scan is not. UK insurers generally exclude self-referred screening scans in people without symptoms. Once a finding has been made, the specialist consultation and any tests to identify it are usually treated as investigation of a clinical problem and are covered by most policies. Please check your benefit with your insurer before booking. Jo Mitchelson can provide a self-pay estimate if you prefer not to involve your insurer.
Do I need a GP referral?
Self-referrals welcome. No GP letter is needed before booking. Appointments at London Bridge Hospital and The Lister Hospital Chelsea within 2–3 days, including video consultations, with outpatient clinics at Canary Wharf and the City of London. Please send the radiology report, the images on disc or by download link if you have them, and any blood test result. Most major insurers are accepted, and a self-pay estimate is provided before you commit to anything.

Book a review of
your scan or blood test result

Self-referrals welcome. Appointments at London Bridge Hospital and The Lister Hospital Chelsea within 2–3 days, including video consultations, with outpatient clinics at Canary Wharf and the City of London. Please send the report, the images and any blood test result.

Book a Consultation → Second Opinion

Jo Mitchelson, PA  · 020 7952 2882 · pa@lungsurgeon.co.uk

St Thomas’ Hospital #1 UK · Guy’s Hospital #2 UK · London Bridge Hospital #10 UK · Newsweek World’s Best Hospitals 2026

Continue Reading

A Finding in the Front of the ChestA mass in the front of the chest on a scan, including possible thymoma. Lump or Prominence on the BreastboneA hard lump in the middle of the chest: the joint in the sternum, the rib cartilage attached to it, and mild pectus shapes. Broken Breastbone After InjurySternal fracture after a seatbelt or airbag injury, what the ECG and troponin rule out, and pain that has not settled by three months. Chest Imaging ExplainedWhat CT, MRI and PET each contribute, and what the phrases in a radiology report mean. Mediastinal SurgeryThe compartments of the mediastinum, what lies in each, and what a mass in the front of the chest can be. ThymomaWhat a thymoma is, when it needs removing, and what the operation involves once the diagnosis is confirmed. Shadow Found on a ScanA shadow on a chest X-ray or CT: what it can be, and what happens next. What Is a Lung Nodule?How a nodule is assessed by size, appearance and change over time, and when it needs treatment. Chest Wall LumpLumps and lesions of the ribs, breastbone and chest wall, most of which are not tumours. Asbestos-Related Pleural DiseasePleural thickening and plaques found on a scan: what they mean and what follow-up is needed. Rare Chest TumoursUncommon tumours found on chest imaging and how they are told apart. Lung Nodule Found on a Heart ScanA nodule reported on a calcium score or CT coronary angiogram: how often it happens, what the figures show, and what the follow-up interval means. Referral Route for Imaging & Screening ClinicsFor radiologists, cardiologists and screening clinics referring a patient with an abnormal chest finding: what to send and what is returned. Specialist Second OpinionIndependent review of your imaging and diagnosis, within 2–3 days.
📅Book 📞020 7952 2882